Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-037582

Chief Financial Officer gave up 89 shares (to pay taxes)

  • Chief Financial Officer acquired 362 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Foster Jonathan P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Exercise or conversion : show line 1 in the form +362 20,595 D
2026-11-16 Shares withheld for taxes : show line 2 in the form −89 $7.14 $635 20,506 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2026-11-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −362 362 70,492 D
Loading xslF345X06/rdgdoc.xml…